Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage

Abstract Liver metastasis is the major cause of death in colorectal cancer (CRC) due to the lack of effective treatment. To explore novel drivers of CRC liver metastasis, the transcriptomes of primary paracancerous, colorectal tumors and metastases from human patients are profiled. It is found that...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaojiao Sun, Junling Zhang, Bingqi Dong, Qingqing Xiong, Xin Wang, Yanlun Gu, Zhiqi Wang, Huiyu Liu, Jixin Zhang, Xu He, Hongjin Liu, Yi Zhong, Chuxiao Yi, Xiaowei Chi, Zhenming Liu, Xiaocong Pang, Yimin Cui
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202400367
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553150688886784
author Xiaojiao Sun
Junling Zhang
Bingqi Dong
Qingqing Xiong
Xin Wang
Yanlun Gu
Zhiqi Wang
Huiyu Liu
Jixin Zhang
Xu He
Hongjin Liu
Yi Zhong
Chuxiao Yi
Xiaowei Chi
Zhenming Liu
Xiaocong Pang
Yimin Cui
author_facet Xiaojiao Sun
Junling Zhang
Bingqi Dong
Qingqing Xiong
Xin Wang
Yanlun Gu
Zhiqi Wang
Huiyu Liu
Jixin Zhang
Xu He
Hongjin Liu
Yi Zhong
Chuxiao Yi
Xiaowei Chi
Zhenming Liu
Xiaocong Pang
Yimin Cui
author_sort Xiaojiao Sun
collection DOAJ
description Abstract Liver metastasis is the major cause of death in colorectal cancer (CRC) due to the lack of effective treatment. To explore novel drivers of CRC liver metastasis, the transcriptomes of primary paracancerous, colorectal tumors and metastases from human patients are profiled. It is found that SLIT‐ and NTRK‐like family member 4 (SLITRK4) is the top upregulated gene in liver metastases and is associated with worse overall survival of CRC patients. Multiple in vitro and in vivo models suggested SLITRK4 promoted CRC tumorigenesis, invasion, migration, and angiogenesis, and inhibition of it restrained CRC tumor growth and liver metastasis with a more profound effect on the tumor microenvironment (TME). Mechanistically, SLITRK4 overexpression significantly activated the PI3K/AKT/NFκB pathway, regulated extracellular matrix organization, and multiple cytokines expression. Furthermore, the results from coculture models and single‐cell RNA sequencing analyses suggested SLITRK4 promoted tumor‐associated macrophages (TAMs) infiltration and polarization. In addition, macrophage depletion significantly inhibited SLITRK4‐induced liver metastasis in CRC. Finally, pharmacological inhibition of SLITRK4 by using lipid‐polymer hybrid nanoparticles (NPs) for systemic siRNA delivery can effectively inhibit CRC liver metastasis. Taken together, these results pinpoint that SLITRK4 regulates CRC tumorigenesis and liver metastasis, and siRNA delivering NPs agents validate the therapeutic potential of targeting SLITRK4 in CRC.
format Article
id doaj-art-6411fc0617264c88be24a6bf6ede4900
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-6411fc0617264c88be24a6bf6ede49002025-01-09T11:44:45ZengWileyAdvanced Science2198-38442025-01-01121n/an/a10.1002/advs.202400367Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated MacrophageXiaojiao Sun0Junling Zhang1Bingqi Dong2Qingqing Xiong3Xin Wang4Yanlun Gu5Zhiqi Wang6Huiyu Liu7Jixin Zhang8Xu He9Hongjin Liu10Yi Zhong11Chuxiao Yi12Xiaowei Chi13Zhenming Liu14Xiaocong Pang15Yimin Cui16State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaDepartment of General Surgery Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaDepartment of General Surgery Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaDepartment of Hepatobiliary Cancer Liver Cancer Center Tianjin Medical University Cancer Institute Tianjin 300060 ChinaDepartment of General Surgery Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaDepartment of Pathology Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaDepartment of Pharmacy Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaDepartment of General Surgery Peking University First Hospital Xishiku Street, Beijing Xicheng 100034 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaState Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing 100191 ChinaAbstract Liver metastasis is the major cause of death in colorectal cancer (CRC) due to the lack of effective treatment. To explore novel drivers of CRC liver metastasis, the transcriptomes of primary paracancerous, colorectal tumors and metastases from human patients are profiled. It is found that SLIT‐ and NTRK‐like family member 4 (SLITRK4) is the top upregulated gene in liver metastases and is associated with worse overall survival of CRC patients. Multiple in vitro and in vivo models suggested SLITRK4 promoted CRC tumorigenesis, invasion, migration, and angiogenesis, and inhibition of it restrained CRC tumor growth and liver metastasis with a more profound effect on the tumor microenvironment (TME). Mechanistically, SLITRK4 overexpression significantly activated the PI3K/AKT/NFκB pathway, regulated extracellular matrix organization, and multiple cytokines expression. Furthermore, the results from coculture models and single‐cell RNA sequencing analyses suggested SLITRK4 promoted tumor‐associated macrophages (TAMs) infiltration and polarization. In addition, macrophage depletion significantly inhibited SLITRK4‐induced liver metastasis in CRC. Finally, pharmacological inhibition of SLITRK4 by using lipid‐polymer hybrid nanoparticles (NPs) for systemic siRNA delivery can effectively inhibit CRC liver metastasis. Taken together, these results pinpoint that SLITRK4 regulates CRC tumorigenesis and liver metastasis, and siRNA delivering NPs agents validate the therapeutic potential of targeting SLITRK4 in CRC.https://doi.org/10.1002/advs.202400367colorectal cancerliver metastasismacrophagenanoparticlesSLITRK4
spellingShingle Xiaojiao Sun
Junling Zhang
Bingqi Dong
Qingqing Xiong
Xin Wang
Yanlun Gu
Zhiqi Wang
Huiyu Liu
Jixin Zhang
Xu He
Hongjin Liu
Yi Zhong
Chuxiao Yi
Xiaowei Chi
Zhenming Liu
Xiaocong Pang
Yimin Cui
Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
Advanced Science
colorectal cancer
liver metastasis
macrophage
nanoparticles
SLITRK4
title Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
title_full Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
title_fullStr Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
title_full_unstemmed Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
title_short Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage
title_sort targeting slitrk4 restrains proliferation and liver metastasis in colorectal cancer via regulating pi3k akt nfκb pathway and tumor associated macrophage
topic colorectal cancer
liver metastasis
macrophage
nanoparticles
SLITRK4
url https://doi.org/10.1002/advs.202400367
work_keys_str_mv AT xiaojiaosun targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT junlingzhang targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT bingqidong targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT qingqingxiong targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT xinwang targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT yanlungu targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT zhiqiwang targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT huiyuliu targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT jixinzhang targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT xuhe targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT hongjinliu targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT yizhong targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT chuxiaoyi targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT xiaoweichi targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT zhenmingliu targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT xiaocongpang targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage
AT yimincui targetingslitrk4restrainsproliferationandlivermetastasisincolorectalcancerviaregulatingpi3kaktnfkbpathwayandtumorassociatedmacrophage